
PERSONAL INFORMATION
Alternate Email :
aselvapandiyan@gmail.com
Designation :
Dean, HOD & Professor
Department & School :
Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology
Qualifications :
Ph.D. FAMS
State Of Domicile :
Delhi
Research Thrust Areas :
Infectious Diseases, Cell Biology, Vaccinolgy, Drug Development
Details Of Courses Taught
Vaccinology, Immunology,Parasitology, Bacteriology, Molecular Biology
PUBLICATIONS
Google Scholar :Publications 86, Citations >3111; h-intex 35
Scopus Author ID : Scopus ID: 57203371147
ORCID :https://orcid.org/0000-0002-2194-1534
VIDWAN :Vidwan id: 164275
BOOKS & BOOK CHAPTERS PUBLISHED
Number Of Books Published By National Publisher :
The Name Of The Publisher :
Number Of Books Published By International Publisher :
1
The Name Of The International Publisher :
SPRINGER
Number Of Book Chapters In Edited Books Of National Publishers :
4
The Name Of The Publisher:
APH India
Malhotra Pub. House
Number Of Book Chapters In Edited Books Of International Publishers :
12
The Name Of The Publisher :
SPRINGER Nature
Springer International
Academic Press
ICRISAT
RESEARCH GRANTS AND CONSULTANCY PROJECTS
Number Of Research Grants From Govt. Funding Agencies As PI/Coordinator :
8
Name Of The Agency And Amount Of Funding Generated :
Department of Biotechnology (BT), Rs. 64 Lakhs; Rs. 178 Lakhs;
Department of Science and Techology SERB (DST-SERB), Rs. 64 Lakhs;
Indian Council of Medical Research (ICMR), Rs. 42 Lakhs; Rs. 50 Lakhs; Rs. 110 Lakhs; Rs. 6 Lakhs;
Biotechnology Industry Research Assistance Council (BIRAC) Rs. 127 Lakhs;
Number Of Research Grants From Govt. Funding Agencies As Co-PI :
2
Name Of The Agency And Amount Of Funding Generated :
Department of Biotechnology (BT), Rs. 153 Lakhs; Rs. 99 Lakhs;
Indian Council of Medical Research (ICMR), Rs. 26.38 Lakhs;
Number Of Research Grants From International And Private Sources As PI :
3
Name Of The Agency And Amount Of Funding Generated :
Number Of Consultancy Projects :
Name Of The Agency And Amount Of Funding Generated :
RESEARCH SUPERVISION
Number Of Master’s Theses/DissertationsGuided :
18
Number Of Ph.D. Guided :
5
Number Of Master’s Theses/DissertationsGuided :
Number Of Co-supervisorPhd :
2
PATENTS
Number Of Patents Granted :
4
Specify National/International :
3 of them were International
1 of it was National
Number Of Patents Applied For :
Specify National/International :
PRESENTATIONS IN CONFERENCES AS SPEAKER/ RESOURCE PERSON
Number Of Presentations In National Or International Conferences In India :
5 International Conferences in India
13 National Conferences in India
Please Specify Invited/Oral/Poster :
All of them were INVITED/ORAL
Number Of Presentations In International Conferences Abroad :
9 International Conferenes in Abroad
Please Specify Invited/Oral/Poster :
All of them were INVITED/ORAL
NATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED
Name Of The Award :
Best Researcher Award
Fellow of Academy Medical of Sciences (FAMS)
Granting Agency :
Galgotias University, Greater Noida, UP, India
National Academy Medical of Sciences, India
Year Of Award :
2024
2024
INTERNATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED
Name Of The Award :
ORISE Fellowship to work in FDA, USA
Fellows award for Research Excellence (FARE)
‘Group Recognition Award’ to Chagas Disease Donor Screening Biological License Application Review Group
Centre Director’s Scientific Achievement Award
Granting Agency :
National Institute of Health, Bethesda MD USA
National Institute of Health, Bethesda MD USA
CBER/Food and Drug Administration, MD, USA
CBER/Food and Drug Administration, MD, USA
Year Of Award :
1999
2002
2007
2009
STAFF DEVELOPMENT/REFRESHER/SHORT TERM TRAINING PROGRAMME/WEBINARS ORGANIZED
Title :
Duration :
Sponsoring Agency :
MEMBER(S) OF NATIONALCOMMITTEES
Life Member of Indian Immunology Society, India
Life Member of Indian Parasitology Society, India
Life Member of Indian Cell Biology Society, India
MEMBER(S) OF INTERNATIONAL COMMITTEES
American Association of Immunologists, USA (2017)
American Society of Cell Biology, USA (2002-2007)
ADMINISTARTIVE RESPONSIBILITIES/ PARTICIPATION IN COMMITTEES OF JAMIA HAMDARD
As In-charge, JH Institute of Molecular Medicine, (2016-2019)
As Head, Department of Molecular Medicine, (2019-2022)
As Head, Department of Food Technology, (2019-2021)
As In-charge, Centre for Virology, (2023-2023)
As Dean, School of Interdisciplinary Sciences and Technology (2024-......)
ANY OTHER
Select list of publications of last 5 years
-
Roshanara, Tandon, R., Puri, N., & Selvapandiyan, A. (2024). Mechanistic insights into LdCen1-LdDRP interaction facilitating UV-induced DNA damage repair in Leishmania donovani. Medical Microbiology and Immunology (In press).
-
Selvapandiyan, A., Shital, S., Sangma, D. A., Jain, M., Karunaweera, N., & Ganguly, N. K. (2025). An update on clinical and pathogenic spectra of leishmaniasis. Expert Review of Molecular Medicine, 1–33.
-
Orucho, V. O., Gupta, A., Masai, R. J., Ondari, E., Singh, O. P., Nyagaka, B., & Selvapandiyan, A. (2024). Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa. Diagnostic Microbiology and Infectious Disease, 111(3), 116655. https://doi.org/10.1016/j.diagmicrobio.2024.116655
-
Shital, M., E., Selvapandiyan, A., & Ganguly, N. K. (2024). An update on recombinant vaccines against leishmaniasis. Indian Journal of Medical Sciences (In press). https://doi.org/10.4103/ijms.ijms_1234_24
-
Roshanara, Tandon, R., Baig, M. S., Das, S., Srivastava, R., Puri, N., Nakhasi, H. L., & Selvapandiyan, A. (2024). Identifying Rab2 protein as a key interactor of Centrin1 essential for Leishmania donovani growth. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.39110117
-
Avishek, K., Beg, M. A., Vats, K., Singh, A. K., Dey, R., Singh, K. P., Singh, R. K., Gannavaram, S., Ramesh, V., Mulla, M. S. A., Bhatnagar, U., Singh, S., Nakhasi, H. L., & Salotra, P., & Selvapandiyan, A. (2024). Manufacturing and preclinical toxicity of GLP-grade gene-deleted attenuated Leishmania donovani parasite vaccine. Scientific Reports, 14(1), 14636.
-
Reyaz, E., Tandon, R., Beg, M. A., Dey, R., Puri, N., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2024). Proteome profile of Leishmania donovani Centrin1-/- parasite-infected human macrophage cells and implications in protective immunity. Microbes and Infectious Diseases, 105340. https://doi.org/10.1016/j.micinf.2024.105340
-
Roshanara, Muthu, S. A., Gulafsha, Tandon, R., & Selvapandiyan, A. (2024). Biophysical evidence for the amyloid formation of a recombinant Rab2 isoform of Leishmania donovani. Protein and Peptide Letters. https://doi.org/10.2174/0109298665299157240327084614
-
Reyaz, E., Puri, N., & Selvapandiyan, A. (2024). Global remodeling of host proteome in response to Leishmania infection. ACS Infectious Diseases, 10(1), 5–19.
-
Madusanka, R. K., Hermali, N., & Selvapandiyan, A. (2023). Antimony resistance and gene expression in Leishmania: Insights from molecular and proteomic studies. Parasitology, 151(1), 1–14. https://doi.org/10.1017/S0031182023001129
-
Tandon, R., Reyaz, E., Roshanara, M., Jadhav, M., Gandhi, R., Dey, R., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2023). Identification of protein biomarkers of attenuation and immunogenicity of Leishmania centrin or p27 gene-deleted live vaccine candidates. Parasitology International, 92, 102661.
-
Vats, K., Tandon, R., Roshanara, M. A., Beg, M., Corrales, R. M., Yagoubat, A., Reyaz, E., Wani, T. H., Baig, M. S., Chaudhury, A., Krishnan, A., Puri, N., Salotra, P., Sterkers, Y., & Selvapandiyan, A. (2023). Interaction of novel proteins, centrin4 and a protein of the centriole, in Leishmania parasite and their effects on parasite growth. Biochimica et Biophysica Acta - Molecular Cell Research, 1870, 119416.
-
Selvapandiyan, A., Puri, N., Kumar, P., Alam, A., Ehtesham, N. Z., Griffin, G., & Hasnain, S. E. (2022). Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: Potential broad-spectrum therapeutic targets against infectious diseases. FEMS Microbiology Reviews, 47.
-
Gupta, A., Sinha, K. M., Abdin, M. J., Puri, N., & Selvapandiyan, A. (2021). NDK/NME proteins: A host-pathogen interface perspective towards therapeutics. Current Genetics, 67, 1–12. https://doi.org/10.1007/s00294-021-01198-9
-
Ahuja, K., Vats, A., Beg, M. A., Kariyawasam, K. K. G. D. U. L., Chaudhury, A., Chatterjee, M., Dey, N. D., & Selvapandiyan, A. (2020). High-resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis. Parasitology International, 75, 102047.
-
Chauhan, C., Singh, P., Muthu, S. A., Parvez, S., Selvapandiyan, A., & Ahmad, B. (2024). Plumbagin accelerates serum albumin amyloid aggregation kinetics and induces fibril polymorphism by promoting non-native β-sheet structures. Biochimica et Biophysica Acta - Proteins and Proteomics, 141028. https://doi.org/10.1016/j.bbapap.2024.141028
-
Jain, P., Mirza, M. A., Reyaz, E., Beg, M. A., Selvapandiyan, A., Ahmad, F. J., & Iqbal, Z. (2024). QbD-assisted development and optimization of doxycycline hyclate- and hydroxyapatite-loaded nanoparticles for periodontal delivery. ACS Omega, 9(4), 4455–4465.
-
Ghosh, S., Kumar, V., Verma, A., Sharma, T., Pradhan, D., Selvapandiyan, A., & Salotra, P. (2022). Genome-wide analysis reveals allelic and chromosome copy number variation in paromomycin-resistant Leishmania donovani. Parasitology Research, 121(11), 3121–3132.
-
Ghosh, S., Verma, A., Kumar, V., Pradhan, D., Selvapandiyan, A., Salotra, P., & Singh, R. (2020). Genomic and transcriptomic analysis for identifying genes and pathways mediating artemisinin resistance in Leishmania donovani. Genes, 11(11), 1362. https://doi.org/10.3390/genes11111362
-
Naqvi, N., Srivastava, R., Selvapandiyan, A., & Puri, N. (2020). Host mast cells in leishmaniasis: Friend or foe? Trends in Parasitology, 36(12), 952–956. https://doi.org/10.1016/j.pt.2020.09.010
-
Zafar, S., Akhter, S., Garg, N., Selvapandiyan, A., Jain, G. K., & Ahmad, F. J. (2020). Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity. European Journal of Pharmaceutics and Biopharmaceutics, 148, 10–26. https://doi.org/10.1016/j.ejpb.2019.12.016

PERSONAL INFORMATION
Alternate Email :
aselvapandiyan@gmail.com
Designation :
Dean, HOD & Professor
Department & School :
Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology
Qualifications :
Ph.D. FAMS
State Of Domicile :
Delhi
Research Thrust Areas :
Infectious Diseases, Cell Biology, Vaccinolgy, Drug Development
Details Of Courses Taught
Vaccinology, Immunology,Parasitology, Bacteriology, Molecular Biology
PUBLICATIONS
Google Scholar :Publications 86, Citations >3111; h-intex 35
Scopus Author ID : Scopus ID: 57203371147
ORCID :https://orcid.org/0000-0002-2194-1534
VIDWAN :Vidwan id: 164275
BOOKS & BOOK CHAPTERS PUBLISHED
Number Of Books Published By National Publisher :
The Name Of The Publisher :
Number Of Books Published By International Publisher :
1
The Name Of The International Publisher :
SPRINGER
Number Of Book Chapters In Edited Books Of National Publishers :
4
The Name Of The Publisher:
APH India
Malhotra Pub. House
Number Of Book Chapters In Edited Books Of International Publishers :
12
The Name Of The Publisher :
SPRINGER Nature
Springer International
Academic Press
ICRISAT
RESEARCH GRANTS AND CONSULTANCY PROJECTS
Number Of Research Grants From Govt. Funding Agencies As PI/Coordinator :
8
Name Of The Agency And Amount Of Funding Generated :
Department of Biotechnology (BT), Rs. 64 Lakhs; Rs. 178 Lakhs;
Department of Science and Techology SERB (DST-SERB), Rs. 64 Lakhs;
Indian Council of Medical Research (ICMR), Rs. 42 Lakhs; Rs. 50 Lakhs; Rs. 110 Lakhs; Rs. 6 Lakhs;
Biotechnology Industry Research Assistance Council (BIRAC) Rs. 127 Lakhs;
Number Of Research Grants From Govt. Funding Agencies As Co-PI :
2
Name Of The Agency And Amount Of Funding Generated :
Department of Biotechnology (BT), Rs. 153 Lakhs; Rs. 99 Lakhs;
Indian Council of Medical Research (ICMR), Rs. 26.38 Lakhs;
Number Of Research Grants From International And Private Sources As PI :
3
Name Of The Agency And Amount Of Funding Generated :
Number Of Consultancy Projects :
Name Of The Agency And Amount Of Funding Generated :
RESEARCH SUPERVISION
Number Of Master’s Theses/DissertationsGuided :
18
Number Of Ph.D. Guided :
5
Number Of Master’s Theses/DissertationsGuided :
Number Of Co-supervisorPhd :
2
PATENTS
Number Of Patents Granted :
4
Specify National/International :
3 of them were International
1 of it was National
Number Of Patents Applied For :
Specify National/International :
PRESENTATIONS IN CONFERENCES AS SPEAKER/ RESOURCE PERSON
Number Of Presentations In National Or International Conferences In India :
5 International Conferences in India
13 National Conferences in India
Please Specify Invited/Oral/Poster :
All of them were INVITED/ORAL
Number Of Presentations In International Conferences Abroad :
9 International Conferenes in Abroad
Please Specify Invited/Oral/Poster :
All of them were INVITED/ORAL
NATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED
Name Of The Award :
Best Researcher Award
Fellow of Academy Medical of Sciences (FAMS)
Granting Agency :
Galgotias University, Greater Noida, UP, India
National Academy Medical of Sciences, India
Year Of Award :
2024
2024
INTERNATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED
Name Of The Award :
ORISE Fellowship to work in FDA, USA
Fellows award for Research Excellence (FARE)
‘Group Recognition Award’ to Chagas Disease Donor Screening Biological License Application Review Group
Centre Director’s Scientific Achievement Award
Granting Agency :
National Institute of Health, Bethesda MD USA
National Institute of Health, Bethesda MD USA
CBER/Food and Drug Administration, MD, USA
CBER/Food and Drug Administration, MD, USA
Year Of Award :
1999
2002
2007
2009
STAFF DEVELOPMENT/REFRESHER/SHORT TERM TRAINING PROGRAMME/WEBINARS ORGANIZED
Title :
Duration :
Sponsoring Agency :
MEMBER(S) OF NATIONALCOMMITTEES
Life Member of Indian Immunology Society, India
Life Member of Indian Parasitology Society, India
Life Member of Indian Cell Biology Society, India
MEMBER(S) OF INTERNATIONAL COMMITTEES
American Association of Immunologists, USA (2017)
American Society of Cell Biology, USA (2002-2007)
ADMINISTARTIVE RESPONSIBILITIES/ PARTICIPATION IN COMMITTEES OF JAMIA HAMDARD
As In-charge, JH Institute of Molecular Medicine, (2016-2019)
As Head, Department of Molecular Medicine, (2019-2022)
As Head, Department of Food Technology, (2019-2021)
As In-charge, Centre for Virology, (2023-2023)
As Dean, School of Interdisciplinary Sciences and Technology (2024-......)
ANY OTHER
Select list of publications of last 5 years
-
Roshanara, Tandon, R., Puri, N., & Selvapandiyan, A. (2024). Mechanistic insights into LdCen1-LdDRP interaction facilitating UV-induced DNA damage repair in Leishmania donovani. Medical Microbiology and Immunology (In press).
-
Selvapandiyan, A., Shital, S., Sangma, D. A., Jain, M., Karunaweera, N., & Ganguly, N. K. (2025). An update on clinical and pathogenic spectra of leishmaniasis. Expert Review of Molecular Medicine, 1–33.
-
Orucho, V. O., Gupta, A., Masai, R. J., Ondari, E., Singh, O. P., Nyagaka, B., & Selvapandiyan, A. (2024). Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa. Diagnostic Microbiology and Infectious Disease, 111(3), 116655. https://doi.org/10.1016/j.diagmicrobio.2024.116655
-
Shital, M., E., Selvapandiyan, A., & Ganguly, N. K. (2024). An update on recombinant vaccines against leishmaniasis. Indian Journal of Medical Sciences (In press). https://doi.org/10.4103/ijms.ijms_1234_24
-
Roshanara, Tandon, R., Baig, M. S., Das, S., Srivastava, R., Puri, N., Nakhasi, H. L., & Selvapandiyan, A. (2024). Identifying Rab2 protein as a key interactor of Centrin1 essential for Leishmania donovani growth. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.39110117
-
Avishek, K., Beg, M. A., Vats, K., Singh, A. K., Dey, R., Singh, K. P., Singh, R. K., Gannavaram, S., Ramesh, V., Mulla, M. S. A., Bhatnagar, U., Singh, S., Nakhasi, H. L., & Salotra, P., & Selvapandiyan, A. (2024). Manufacturing and preclinical toxicity of GLP-grade gene-deleted attenuated Leishmania donovani parasite vaccine. Scientific Reports, 14(1), 14636.
-
Reyaz, E., Tandon, R., Beg, M. A., Dey, R., Puri, N., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2024). Proteome profile of Leishmania donovani Centrin1-/- parasite-infected human macrophage cells and implications in protective immunity. Microbes and Infectious Diseases, 105340. https://doi.org/10.1016/j.micinf.2024.105340
-
Roshanara, Muthu, S. A., Gulafsha, Tandon, R., & Selvapandiyan, A. (2024). Biophysical evidence for the amyloid formation of a recombinant Rab2 isoform of Leishmania donovani. Protein and Peptide Letters. https://doi.org/10.2174/0109298665299157240327084614
-
Reyaz, E., Puri, N., & Selvapandiyan, A. (2024). Global remodeling of host proteome in response to Leishmania infection. ACS Infectious Diseases, 10(1), 5–19.
-
Madusanka, R. K., Hermali, N., & Selvapandiyan, A. (2023). Antimony resistance and gene expression in Leishmania: Insights from molecular and proteomic studies. Parasitology, 151(1), 1–14. https://doi.org/10.1017/S0031182023001129
-
Tandon, R., Reyaz, E., Roshanara, M., Jadhav, M., Gandhi, R., Dey, R., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2023). Identification of protein biomarkers of attenuation and immunogenicity of Leishmania centrin or p27 gene-deleted live vaccine candidates. Parasitology International, 92, 102661.
-
Vats, K., Tandon, R., Roshanara, M. A., Beg, M., Corrales, R. M., Yagoubat, A., Reyaz, E., Wani, T. H., Baig, M. S., Chaudhury, A., Krishnan, A., Puri, N., Salotra, P., Sterkers, Y., & Selvapandiyan, A. (2023). Interaction of novel proteins, centrin4 and a protein of the centriole, in Leishmania parasite and their effects on parasite growth. Biochimica et Biophysica Acta - Molecular Cell Research, 1870, 119416.
-
Selvapandiyan, A., Puri, N., Kumar, P., Alam, A., Ehtesham, N. Z., Griffin, G., & Hasnain, S. E. (2022). Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: Potential broad-spectrum therapeutic targets against infectious diseases. FEMS Microbiology Reviews, 47.
-
Gupta, A., Sinha, K. M., Abdin, M. J., Puri, N., & Selvapandiyan, A. (2021). NDK/NME proteins: A host-pathogen interface perspective towards therapeutics. Current Genetics, 67, 1–12. https://doi.org/10.1007/s00294-021-01198-9
-
Ahuja, K., Vats, A., Beg, M. A., Kariyawasam, K. K. G. D. U. L., Chaudhury, A., Chatterjee, M., Dey, N. D., & Selvapandiyan, A. (2020). High-resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis. Parasitology International, 75, 102047.
-
Chauhan, C., Singh, P., Muthu, S. A., Parvez, S., Selvapandiyan, A., & Ahmad, B. (2024). Plumbagin accelerates serum albumin amyloid aggregation kinetics and induces fibril polymorphism by promoting non-native β-sheet structures. Biochimica et Biophysica Acta - Proteins and Proteomics, 141028. https://doi.org/10.1016/j.bbapap.2024.141028
-
Jain, P., Mirza, M. A., Reyaz, E., Beg, M. A., Selvapandiyan, A., Ahmad, F. J., & Iqbal, Z. (2024). QbD-assisted development and optimization of doxycycline hyclate- and hydroxyapatite-loaded nanoparticles for periodontal delivery. ACS Omega, 9(4), 4455–4465.
-
Ghosh, S., Kumar, V., Verma, A., Sharma, T., Pradhan, D., Selvapandiyan, A., & Salotra, P. (2022). Genome-wide analysis reveals allelic and chromosome copy number variation in paromomycin-resistant Leishmania donovani. Parasitology Research, 121(11), 3121–3132.
-
Ghosh, S., Verma, A., Kumar, V., Pradhan, D., Selvapandiyan, A., Salotra, P., & Singh, R. (2020). Genomic and transcriptomic analysis for identifying genes and pathways mediating artemisinin resistance in Leishmania donovani. Genes, 11(11), 1362. https://doi.org/10.3390/genes11111362
-
Naqvi, N., Srivastava, R., Selvapandiyan, A., & Puri, N. (2020). Host mast cells in leishmaniasis: Friend or foe? Trends in Parasitology, 36(12), 952–956. https://doi.org/10.1016/j.pt.2020.09.010
-
Zafar, S., Akhter, S., Garg, N., Selvapandiyan, A., Jain, G. K., & Ahmad, F. J. (2020). Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity. European Journal of Pharmaceutics and Biopharmaceutics, 148, 10–26. https://doi.org/10.1016/j.ejpb.2019.12.016